Understanding LC-MS Peptide Identification

What is LC-MS?

LC-MS stands for liquid chromatography–mass spectrometry.

It combines two analytical techniques:

1. Liquid chromatography separates components within a sample.
2. Mass spectrometry detects ions according to their mass-to-charge ratio.

The liquid-chromatography stage helps separate the intended peptide from other detectable components before material enters the mass spectrometer.

The mass spectrometer then converts molecules into gas-phase ions and measures their mass-to-charge ratio, written as m/z.

The combined technique is useful because chromatographic separation and mass-based detection provide different types of selectivity.

Why peptides often produce several ion signals

Peptides commonly form ions carrying more than one electrical charge.

A single peptide may therefore appear as a series of related signals representing:

• singly charged ions;
• doubly charged ions;
• triply charged ions;
• ions with still higher charge states.

These signals do not necessarily indicate several different peptides. Analytical software can use the charge-state pattern to calculate a deconvoluted molecular mass.

The report should state whether the displayed value is:

• a raw m/z value;
• a monoisotopic mass;
• an average molecular mass;
• or a deconvoluted neutral mass.

These values should not be compared without confirming that the same calculation basis is being used.

Intact-mass analysis

Intact-mass analysis evaluates the mass of the peptide molecule without deliberately breaking it into smaller sequence fragments.

The observed mass can be compared with the theoretical mass calculated for the intended structure.

The calculation must account for the actual chemical form, including relevant:

• terminal groups;
• conjugated groups;
• lipid chains;
• linkers;
• disulphide bonds;
• counter-ions where applicable;
• covalent modifications.

Agreement between observed and theoretical mass supports identity, but it does not always prove the complete amino-acid sequence.

Different structures can sometimes have the same or very similar nominal mass.

Tandem mass spectrometry

Tandem mass spectrometry may be written as:

• MS/MS;
• LC-MS/MS;
• tandem MS.

In MS/MS analysis, a selected precursor ion is fragmented. The resulting product-ion pattern may provide information about the peptide's sequence or structural features.

Sequence coverage describes how much of the intended sequence is supported by the observed fragment data.

A report should not claim complete sequence confirmation unless the data and interpretation genuinely support that conclusion.

What should appear in an LC-MS identity report?

A useful peptide LC-MS report may include:

What LC-MS can support

Depending on the method and data, LC-MS may support:

• molecular-mass confirmation;
• detection of some mass-related variants;
• distinction between chromatographically separated components;
• confirmation of selected chemical modifications;
• investigation of degradation products;
• sequence-related evidence through MS/MS;
• comparison with a reference material.

What LC-MS does not prove by itself

An LC-MS identity result does not independently establish:

• chromatographic purity;
• absolute peptide content;
• quantity per vial;
• water content;
• residual-solvent content;
• counter-ion quantity;
• elemental impurities;
• sterility;
• bacterial endotoxin status;
• stability throughout storage;
• suitability for human or veterinary use.

A mass spectrum showing the expected molecular mass is therefore not a complete Certificate of Analysis.

Common interpretation limitations

Isomeric amino acids

Some amino acids have the same elemental composition and molecular mass. A simple intact-mass result may not distinguish between every sequence arrangement or structural isomer.

Co-eluting components

Two components may leave the chromatographic column at similar times. The mass spectrometer may detect both, but interpretation depends on resolution, ionisation and data processing.

Adducts

Peptide ions may associate with substances such as sodium, potassium or solvent-related species. These can produce additional signals.

In-source fragmentation

Some fragmentation may occur during ion formation rather than during a controlled MS/MS experiment.

Ionisation response

Different compounds do not necessarily generate equal signal intensity. A strong ion signal does not automatically mean that the material is present in the greatest absolute quantity.

Chemical-form mismatch

A database value may describe a free peptide, salt, conjugate or other defined form that differs from the tested batch. The expected mass must match the material actually supplied.

Why orthogonal testing matters

Orthogonal methods use different analytical principles.

For peptide identity, a second method may include:

• peptide mapping;
• amino-acid analysis;
• nuclear magnetic resonance;
• sequence analysis;
• comparison with a qualified reference standard;
• an appropriately selective chromatographic method.

Combining independent analytical approaches reduces the risk of relying on a single measurement.

LC-MS report checklist

Before accepting an LC-MS identity claim, ask:

1. Does the product name match the material?
2. Does the batch number match the vial?
3. Is the chemical form stated?
4. Is the theoretical mass shown?
5. Is the calculation basis clear?
6. Is the observed mass shown?
7. Is the permitted mass tolerance stated?
8. Are relevant spectra included?
9. Are charge states explained?
10. Is the conclusion supported by the data?
11. Is another identity method available?
12. Is the report traceable to the testing laboratory?